Skip to content

Clinical trials

Huntington Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Huntington Disease Country / region: Australia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20092
20111
20122
20132
20141
20151
20172
20191
20201
20211
20223
20232
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated8
Active, not recruiting4
Recruiting4
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wave Life Sciences USA, Inc.5
Hoffmann-La Roche3
Novartis Pharmaceuticals3
CHDI Foundation, Inc.2
Massachusetts General Hospital2
Prilenia2
Skyhawk Therapeutics, Inc.2
Supernus Pharmaceuticals, Inc.2
Auspex Pharmaceuticals, Inc.1
HP Therapeutics Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Huntington Disease28
Chorea3
Neurodegenerative Diseases2
Rare Diseases2
Mitochondrial Diseases1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.